Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices
Automation
IT & Software
Return to: PBR Home | Automation | IT & Software

IT & Software

Cerulean doses first patient in Phase I/IIa trial of CRLX301 to treat advanced solid tumors By PBR Staff Writer
Cerulean Pharma has dosed first patient in its Phase I/IIa trial of CRLX301 for the treatment of advanced solid tumor malignancies.
Automation > IT & Software > News
BioBlast receives notice of patent issuance for new fusion protein-based platform to treat Friedrich's Ataxia Bio Blast Pharma a clinical-stage biotechnology company committed to developing clinically meaningful therapies for patients with rare and ultra-rare genetic diseases, announced today it has received a Notice of Patent Issuance for patent no. 8,912,147 from the US Patent and Trademark Office (USPTO) for a composition-of-matter patent for its novel fusion protein for Friedrich's Ataxia (referred to as BB-FA) that is built on its mitochondrial protein replacement (mPRT) platform.
Automation > IT & Software > News Halozyme, Janssen to develop and commercialize products using Enhanze technology By PBR Staff Writer
US-based biopharmaceutical firm Halozyme Therapeutics has entered into a worldwide collaboration and license agreement with Janssen Biotech to develop and commercialize products combining Janssen compounds with Halozyme's Enhanze technology.
Automation > IT & Software > News
See more IT & Software news

Latest IT & Software News and Insight

View all IT & Software news or find news targeted to your interests
Portage further validates new proprietory cell permeable peptide platform technology
Portage Biotech, is pleased to announce that its wholly owned subsidiary Portage Pharmaceuticals has further validated its platform cell penetrating peptide technology for safely delivering a potent anti-inflammatory cargo into eye tissues.
Automation > IT & Software > News
PPD, ERT partner to improve drug development
Pharmaceutical Product Development, and ERT announced a strategic partnership to facilitate delivery of ERT’s comprehensive solutions for patient safety and efficacy endpoint data collection to help biopharmaceutical clients conduct clinical trials in a more efficient and cost-effective manner.
Automation > IT & Software > News
Formpipe Extends Agreement with the Swedish Tax Agency to a Value of SEK13.7m
The Swedish Tax Agency extends their agreement regarding support and maintenance for the ECM product Platina. The value amounts to SEK13.7m over a five-year period.
Automation > IT & Software > Press Releases
X-Chem, Alexion to discover new therapies for severe and ultra-rare disorders
By PBR Staff Writer
US-based biotechnology firm X-Chem has entered into a drug discovery collaboration with Alexion (ALXN) for new therapies to treat patients with severe and ultra-rare disorders.
Automation > IT & Software > News
Pieris begins Phase I trial of anemia drug compound PRS-080
By PBR Staff Writer
Germany-based biotechnology firm Pieris has started a Phase I clinical trial of PRS-080, an anti-hepcidin Anticalin therapeutic protein designed to treat anemia.
Automation > IT & Software > News
Formpipe Receives Order on Cloud Service for Archiving Worth SEK1.3m
Formpipe receives an order on the ECM product Long-Term Archive from the National Agency for Special Needs Education and Schools. The order value amounts to SEK1.3m over a two-year period.
Automation > IT & Software > Press Releases
Navidea forms Macrophage Therapeutics business unit to explore Therapeutic applications of Manocept
Navidea Biopharmaceuticals announced the formation of a new business unit, Macrophage Therapeutics, to further explore therapeutic applications for the Manocept platform.
Automation > IT & Software > News
Vital Connect, Medidata partner to enhance clinical trials with continuous Vital sign monitoring
Vital Connect announced that its FDA-cleared wearable biosensor, HealthPatch MD, is now available for use in clinical trials in partnership with Medidata (MDSO), a leading global provider of cloud-based solutions for clinical research in life sciences.
Automation > IT & Software > News
FDA accepts filing of Aprecia's NDA for first product using ZipDose technology
By PBR Staff Writer
The US Food and Drug Administration (FDA) has accepted for filing Aprecia Pharmaceuticals' new drug application (NDA) for the first product using its ZipDose technology, a formulation platform that allows medicine to swiftly disperse in the patient’s mouth with a sip of water or other liquid.
Automation > IT & Software > News
MSP Kofel – Analytical Accessories and Software Specialists
MSP Kofel provides analytical scientists with software and databases for interpretation, confirmation and archival of spectra, chromatographic data, structures and chemical compound information.
Automation > IT & Software > Suppliers
View all IT & Software news or find news targeted to your interests

Buy the latest industry research online today!
Shire Plc : Pharmaceuticals & Healthcare - Company Profile, SWOT & Financial Report 03 October 2013 This report is a crucial resource for industry executives and anyone looking to access key information about "Shire Plc" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Buy online from $250